Synthesis of Spin-ladder Sr_(14)Cu_(24)O_(41)Material by Citrates Sol-gel Method

A new process to synthesize polycrystalline samples of Sr14Cu24O41 was presented. Firstly, dry gel powder of Sr14Cu24O41 was synthesized by the citrates sol-gel method, using Sr（NO3）2, Cu（NO3）2, ethylene glycol and citrate acid as raw materials. Then, polycrystalline samples of Sr14Cu24O41 were prepared by solid-state reaction. Thermal Gravimetric and Differential Thermal Analysis（TG-DTA） showed that the temperature for solid-state reaction is at 942 ℃. The samples are identified to be single phase by X-ray Diffraction（XRD） and Scanning Electron Microscopy（SEM）. The SEM pictures showed that the first-step particles were at even size of about 100 nm by this technique. The electronic transport measurements showed that the doping compound were semiconductor with a crossover temperature T in the Arrhenius plot of the resistivity versus temprature.

Bio-inspired Hydroxyapatite/Gelatin Transparent Nanocomposites

Hydroxyapatite(HA)nanoparticles impart outstanding mechanical properties to organicinorganic nanocomposites in bone.Inspired by the composite structure of HA nanoparticles and collagen in bone,a high performance HA/gelatin nanocomposite was first developed.The nanocomposites have much better mechanical properties(elongation at break 29.9%,tensile strength 90.7 MPa,Young’s modulus 5.24 GPa)than pure gelatin films(elongation at break 9.3%,tensile strength 90.8 MPa,Young’s modulus 2.5 GPa).In addition,the composite films keep a high transmittance in visible wavelength range from 0%to 60%of the HA solid content.These differences in properties are attributed to the homogeneous distribution of HA nanoparticles in the gelatin polymer matrix and the strong interaction between the particle surfaces and the gelatin molecules.This protocol should be promising for HA-based nanocomposites with enhanced mechanical properties for biomedical applications.

Phosphotungstic acid immobilized on amino-functionalized TS-1 zeolite as a solid acid catalyst for the synthesis of tributyl citrate

The amino-functionalization of TS-1 zeolite followed by immobilization of phosphotungstic acid(HPW)was presented to prepare a strong solid acid catalyst for the synthesis of bio-based tributyl citrate from the esterification of citric acid and n-butanol.γ-Aminopropyltriethoxysilane(APTES)was first grafted on the TS-1 zeolite via the condensation reactions with surface hydroxyl groups,and subsequently the HPW was immobilized via the reaction between the amino groups and the protons from HPW-forming strong ionic bonding.The Keggin structure of HPW and MFI topology of TS-1 zeolite were well maintained after the modifications.The amino-functionalization generated abundant uniformly distributed active sites on TS-1 for HPW immobilization,which promoted the dispersity,abundance,as well as the stability of the acid sites.The tetrahedrally coordinated framework titanium and non-framework titania behaved as weak Lewis acid sites,and the protons from the immobilized HPW acted as the moderate or strong Brønsted acid sites.An optimized TBC yield of 96.2%(mol)with a conversion of-COOH of 98.1%(mol)was achieved at 150℃for 6 h over the HPW immobilized on amino-functionalized TS-1.The catalyst exhibited good stability after four consecutive reaction runs,where the activity leveled off at still a relatively high level after somewhat deactivation possibly caused by the leaching of a small portion of weakly anchored APTES or HPW.

Mechanism of action of Linggui Zhugan Decoction in treating non-alcoholic fatty liver disease using untargeted metabolomics approach

Background:Non-alcoholic fatty liver disease(NAFLD)is a liver disorder characterized by the accumulation and degeneration of fat in the liver cells,a condition that may further deteriorate and lead to cirrhosis and liver cancer.Numerous studies showed that metabolic dysfunction can promote NAFLD development.Linggui Zhugan Decoction(LGZGD)has therapeutic effects on NAFLD.The mechanism of LGZGD still remains unclear.This study was to examine the impact of LGZGD on the metabolic processes involved in the development of NAFLD.Methods:A mice model of NAFLD was treated with LGZGD.The therapeutic potential of LGZGD was evaluated by assessing the activity of transaminases,lipids levels of blood,and pathological changes in the liver of the mice model of NAFLD.Additionally,this study also evaluated the influence of LGZGD on liver inflammation and oxidative stress.Results:The results of untargeted metabolomics analysis showed that LGZGD reduced the disordered lipid metabolism in NAFLD mice.LGZGD improved the oxidative stress and also reduced the levels of pro-inflammatory cytokines in the liver.Untargeted metabolomics analysis of liver samples revealed that LGZGD treatment improved metabolic disorders,including alanine,aspartate,glutamate,glycerophospholipid metabolism,and citrate cycle.Further RT-qPCR and Western blot results showed that LGZGD could regulate the expression of key enzymes in the metabolic pathway of the citrate cycle,including ATP-citrate lyase(ACLY),alanine-glyoxylate aminotransferase-2(AGXT2),phosphatidylethanolamine N-methyltransferase(PEMT),and succinate dehydrogenase(SDH).Conclusion:We found that LGZGD can treat NAFLD by reducing inflammatory responses,inhibiting oxidative stress,regulating alanine,aspartate,glutamate,and glycerophospholipid metabolism,and citrate cycle pathways.

Usefulness of Newly Devised Clomiphene Citrate Administration Method Compared with the Conventional Method in Ovulation and Pregnancy

Objective: Since not all women wish to conceive a child through aggressive treatment, we investigated the usefulness of modified repeated intracyclic clomiphene citrate (CC) therapy (repeated CC therapy) as a newly devised administration method. Methods: We evaluated the effects of CC administration on menstrual cycle length and retrospectively compared ovulation and pregnancy in 220 women who received CC at our hospital. Patients in the conventional method group received 50 mg per day for five days, starting on the fifth day of menstruation (withdrawal bleeding). Groups with and without menstrual cycle shortening after conventional CC administration were compared. The repeated CC therapy group was also compared with the non-shortened group. Repeated CC therapy was administered for the first five days as in the conventional method, and a second five-day repeat treatment was administered after an interval of five to seven days. Pregnancy rates, including indirect pregnancies, were evaluated by three different methods. Results: Ovulation and pregnancy rates were significantly better in the shortened group than in the non-shortened group (P < 0.001 and P = 0.010, respectively). Even in the non-shortened group, ovulation and pregnancy rates including indirect pregnancies were significantly improved when ovulation was observed with repeated CC therapy (P < 0.001 and P = 0.022, respectively). Conclusions: For patients whose menstrual cycle was not improved or shortened, repeated CC therapy as the newly devised CC administration method is useful as the next step after the conventional CC administration method.

Analysis of the Effect of High-Dose Segmental Citrate Anticoagulation in High Flux Hemodialysis

Objective:To analyze the clinical effect of high-dose citrate in segmental extracorporeal anticoagulation for high-throughput hemodialysis.Methods:The subjects included in this study were admitted to the hospital for maintenance hemodialysis treatment from January 2021 to January 2023.All patients had a high risk of bleeding and received 4%trisodium citrate anticoagulant treatment,administered at a rate of 200 mL/h before and after the dialyzer.The anticoagulant effects achieved by the patients were observed and analyzed.Results:The total number of patients who received high-dose segmented citrate extracorporeal anticoagulation dialysis treatment was 50,with each patient undergoing 100 treatments.During the treatment,2 patients had to end the treatment early due to transmembrane pressure exceeding 30 mmHg and an increase in venous pressure exceeding 250 mmHg;the treatment times for these patients were 20 minutes and 200 minutes,respectively.The remaining patients successfully completed the 4-hour treatment.Blood pH and calcium ion concentration in the venous pot were monitored.It was observed that before dialysis,after 2 hours of dialysis,and at the end of dialysis,the blood pH of the patients remained within a relatively normal range.Although some patient levels changed after dialysis,they remained within the normal range.No adverse reactions(such as numbness of the limbs or convulsions)were observed during the anticoagulant treatment.Conclusion:Administering 4%trisodium citrate at a rate of 200 mL/h before and after the dialyzer achieves a good anticoagulant effect,maintains the patient’s blood gas levels within the normal range at the end of dialysis,and causes no adverse reactions.

Management of regional citrate anticoagulation for continuous renal replacement therapy:guideline recommendations from Chinese emergency medical doctor consensus

Continuous renal replacement therapy(CRRT)is widely used for treating critically-ill patients in the emergency department in China.Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT.Regional citrate anticoagulation(RCA)has been shown to potentially be safer and more effective,and is now recommended as the preferred anticoagulant method for CRRT.However,there is still a lack of unified standards for RCA management in the world,and there are many problems in using this method in clinical practice.The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association(CMDA)organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues,including the advantages and disadvantages of RCA in CRRT anticoagulation,the principle of RCA,parameter settings for RCA,monitoring of RCA(mainly metabolic acid-base disorders),and special issues during RCA.Based on the latest available research evidence as well as the paneled experts'clinical experience,considering the generalizability,suitability,and potential resource utilization,while also balancing clinical advantages and disadvantages,a total of 16 guideline recommendations were formed from the experts'consensus.

Magnetic resonance imaging focused on the ferritin heavy chain 1 reporter gene detects neuronal differentiation in stem cells

The neuronal differentiation of mesenchymal stem cells offers a new strategy for the treatment of neurological disorders.Thus,there is a need to identify a noninvasive and sensitive in vivo imaging approach for real-time monitoring of transplanted stem cells.Our previous study confirmed that magnetic resonance imaging,with a focus on the ferritin heavy chain 1 reporter gene,could track the proliferation and differentiation of bone marrow mesenchymal stem cells that had been transduced with lentivirus carrying the ferritin heavy chain 1 reporter gene.However,we could not determine whether or when bone marrow mesenchymal stem cells had undergone neuronal differentiation based on changes in the magnetic resonance imaging signal.To solve this problem,we identified a neuron-specific enolase that can be differentially expressed before and after neuronal differentiation in stem cells.In this study,we successfully constructed a lentivirus carrying the neuron-specific enolase promoter and expressing the ferritin heavy chain 1 reporter gene;we used this lentivirus to transduce bone marrow mesenchymal stem cells.Cellular and animal studies showed that the neuron-specific enolase promoter effectively drove the expression of ferritin heavy chain 1 after neuronal differentiation of bone marrow mesenchymal stem cells;this led to intracellular accumulation of iron and corresponding changes in the magnetic resonance imaging signal.In summary,we established an innovative magnetic resonance imaging approach focused on the induction of reporter gene expression by a neuron-specific promoter.This imaging method can be used to noninvasively and sensitively detect neuronal differentiation in stem cells,which may be useful in stem cell-based therapies.

A novel herbal combination ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with letrozole-induced polycystic ovary syndrome

Objective:To investigate the potential activity of novel herbal combination and novel herbal formulation(syrup)in female Sprague Dawley rats with letrozole-induced polycystic ovary syndrome(PCOS).Methods:Forty-two rats were randomly divided into seven groups with six rats in each group.Group 1 received 0.5%carboxy methylcellulose orally for 37 days and served as the normal control group.Group 2 was orally administered with letrozole of 1 mg/kg for 21 days and served as the PCOS induction group without treatment.Group 3 to 7 were administered with letrozole of 1 mg/kg for 21 days orally to induce PCOS,and then respectively received clomiphene citrate at 1 mg/kg,100 and 200 mg/kg of novel herbal combination,200 mg/kg of novel herbal formulation(syrup),and 400 mg/kg of marketed formulation of Pushyanuga churna,once daily for 15 days.Effects of the novel herbal combination and its syrup formulation were evaluated on the hormonal profile,the levels of antioxidants,the lipid profile and on the ovarian morphology,using letrozole-induced PCOS model in rats.Results:Letrozole caused alterations in hormonal levels and lipid levels similar to PCOS and ovarian histology showed presence of ovarian cysts confirming the induction of PCOS in rats.On treatment with the novel herbal combination and its syrup formulation in PCOS-induced rats,the altered hormonal and lipid profiles showed significant recovery to normal levels.Ovarian histology confirmed the restoration of folliculogenesis in the PCOS-induced rats.The treatment with the syrup formulation of novel herbal combination was found to be more effective than novel herbal combination and showed better recovery in various parameters evaluated.The results of the study,however,suggested that treatment with novel herbal combination and its syrup formulation provided minimal protection against oxidative stress caused due to the induction of PCOS.Conclusions:The integrated approach for management of PCOS is to counterbalance the limitations associated with modern therapy.Both the novel herbal combination and the syrup formulation of novel herbal combination show efficacy in the management of PCOS in rats and restore folliculogenesis in the ovary.The syrup formulation of novel herbal combination is most effective in the management of PCOS and shows potential to be developed as an adjuvant therapeutic agent.

Studies on Stability and Moisture Retention of Urea and Its Derivatives

The effect of triethyl citrate(TEC)on the stability of cream preparations containing urea or hydroxyethyl urea along with their moisturizing effect on skin was investigated.The results showed that creams incorporating urea or hydroxyethyl urea led to increase in pH value after a long-term and high-temperature storage.pH change in the latter one was relatively smaller.With the addition of TEC,the elevated pH of the formula system was suppressed.In the situation of stable formula,the higher the TEC added,the more significant inhibition effect on the pH change was observed.In the moisture retention test in vivo,compared to 27.19%moisture rate in negative control,cream preparations containing 5%urea or 5%hydroxyethyl urea had remarkable moisturizing effect,which were all higher than 52%.The latter one was relatively more prominent.There is no significant effect on moisturizing effect for product with TEC additive.

Preparation of high active Pt/C cathode electrocatalyst for direct methanol fuel cell by citrate-stabilized method

Platinum nanoparticles supported on carbons（Pt/C,60%,mass fraction） electrocatalysts for direct methanol fuel cell（DMFC） were prepared by citrate-stabilized method with different reductants and carbon supports.The catalysts were characterized by X-ray diffraction（XRD）,transmission electron microscopy（TEM） and cyclic voltammetry（CV）.It is found that the size of Pt nanoparticles on carbon is controllable by citrate addition and reductant optimization,and the form of carbon support has a great influence on electrocatalytic activity of catalysts.The citrate-stabilized Pt nanoparticles supported on BP2000 carbon,which was reduced by formaldehyde,exhibit the best performance with about 2 nm in diameter and 66.46 m2/g（Pt） in electrocatalytic active surface（EAS） area.Test on single DMFC with 60%（mass fraction） Pt/BP2000 as cathode electrocatalyst showed maximum power density at 78.8 mW/cm2.

Electrochemical reduction process of Co(Ⅱ) in citrate solution

Effects of citrate concentration and pH on the electrochemical reduction process of Co（Ⅱ） were investigated by cyclic voltammetry（CV） and electrochemical impedance spectroscopy（EIS）. The results show that Co（Ⅱ） is reduced into two species which are free Co2＋ and [Co（C6H607）] in the solution composed of 0.05 mol/L CoS04·5H2O, 0.20 mol/L Na2SO4 and 0-0.40 mol/L C6H5O7Na3·2H2O in the pH range of 3-9. The reduction behavior depends on the pH of the solution. Co（H） is mainly reduced into the form of free Co^2＋ at pH 3 and into the form of [Co（C6H6O7）] at the pH range of 4-6 in citrate solution. The [Co（C6H6O7）] is first reduced to an intermediate state and then to Co°. Adsorption of the intermediate state exists on the surface of the electrode. Co（Ⅱ） is difficult to be reduced in the solution with the pH above 7, because the existing Co（Ⅱ）-citrate complex species [Co（C6H5O7）]- and [Co（C6H4O7）]2- are more difficult to be reduced than the hydrogen ion.

Convenient synthesis of silver nanoplates with adjustable size through seed mediated growth approach

Silver nanoplates,with average thickness about 5 nm and average tunable size from 40 to 500 nm,were synthesized via a simple room-temperature solution-phase chemical reduction method in the presence of appropriate concentration of trisodium citrate and silver seeds.The optical in-plane dipole plasmon resonance bands of these silver plates could be tuned from 520 to 1100 nm.Control experiments were explored for understanding of the growth mechanism.It is found that both the amount of citrate ions and the small silver seeds added to the growth solution are the key to controlling the silver nanoplates without changing their thickness and crystal structure.Small silver seeds are found to play an important role in the formation of large thin silver nanoplates when poly（vinylpyrrolidone）（PVP） are used as capping agent.

枸橼酸铁铵在磁共振胰胆管成像中应用价值

目的探讨口服枸橼酸铁铵前后对MRCP的应用价值。方法对35例怀疑有胰胆管疾病的患者口服枸橼酸铁铵前后的MRCP图像质量进行自身对照研究。结果服用枸橼酸铁铵前后MRCP的图像质量有明显提高(P<0.001)。口服枸橼酸铁铵后,可有效抑制胃、十二指肠肠道内的液体高信号。结论枸橼酸铁铵作为一种口服阴性对比剂,应用于MRCP成像检查中可以显著提高图像质量。

Larvicidal and repellent properties of some essential oils against Culex tritaeniorhynchus Giles and Anopheles subpictus Grassi(Diptera:Culicidae)

Objective:To investigate the larvicidal and repellent properties of essential oils from various parts of four plant species Cymbopogan citrates,Cinnamomum zeylanicum,Rosmarinus of ficinalis and Zingiber of ficinale against Culex tritaeniorhynchus（Cx.tritaeniorhynchus） and Anopheles subpictus（An.subpktus）.Methods:Essential oils were obtained by hydro-distillation method.The mosquitoes were reared in the vector control laboratory and twenty five late third ins tar larvae of Cx.tritaeniorhynchus and An.subpictus were exposed to based on the wide range and narrow range test,essential oil tested at various concentrations ranging from 25 to 250 ppm.The larval mortality was observed after 24 h under the laboratory conditions.The repellent efficacy was determined against two mosquito species at three concentrations viz., 1.0,2.5 and 5.0 mg/cm2 under laboratory conditions.Results:Results showed all the four plant essential oil produced significant larval mortality against two mosquito species.However,the highest larvicidal activity was observed in the essential oil from Zingiber of ficinale against Cx. tritaeniorhynchus and An.subpktus with the LC50 and LC90 values as 98.83,57.98 ppm and 186.55, 104.23 ppm,respectively.All the four essential oil shows significant repellency against Cx. tritaeniorhynchus than An.subpktus.Among four essential oil tested the highest repellency was observed in Zingiber of ficinale,a higher concentration of 5.0 mg/cm2 provided 100%protection up to 150 and 180 min against Cx.tritaeniorhynchus and An.subpktus,respectively.Conclusions: In this work,it can be concluded that four essential oils which were distilled from Cymbopogan citrates,Cinnamomum zeylanicum,Rosmarinus of ficinalis and Zingiber of ficinale showed promising larvicidal and repellent agent against Cx.tritaeniorhynchus and An.subpktus.

治疗深部真菌感染的靶向抗真菌新药——艾瑞芬净(ibrexafungerp)

近二十多年来,多种因素导致临床上侵袭性真菌感染的发病率不断上升,在各种疾病治疗过程中过多使用化学治疗或放射治疗,使机体免疫功能受到损伤或出现缺陷,增加了真菌感染的发病率。侵袭性真菌感染主要是真菌侵入患者的机体,侵袭各个组织、器官和血液系统,导致患者出现严重的炎症反应和组织损伤。而抗侵袭性真菌感染的新药研发远不能满足临床治疗的需要。二十多年来临床上使用的安全有效品种主要是三唑类、多烯类及棘白菌素等3类药物,并且受到耐药性和不良反应等因素的制约,研发新型抗真菌药已迫在眉睫。2002年6月,美国Scynexis制药公司研制的Ibrexafungerp(艾瑞芬净)是具有全新作用机制的新一代三萜类抗真菌新药,靶向β-1,3-葡聚糖合酶,破坏其完整的细胞壁,直接杀灭真菌细胞。该公司最初与美国默克公司签订许可协议,授予默克公司在全球独家开发权;在2013年5月,Scynexis制药公司要求修改合作协议,收回对该产品的开发和商业化权,答应支付默克公司阶段性补偿款和专利权使用费。2013年9月,Scynexis制药公司与俄罗斯制药商R-Pharm公司签订在俄罗斯和土耳其开发艾瑞芬净及其商业化的协议。2021年2月,中国江苏豪森药业公司与Scynexis制药公司签订在大中华区合作开发艾瑞芬净及其商业化的协议。2020年10月14日Scynexis制药公司向美国食品药品管理局(FDA)提出枸橼酸艾瑞芬净片剂上市申请,该品曾获得罕用药、快速通道、合格感染疾病产品(QIDP)和优先审评等资质。2021年6月1日获FDA批准上市,用于成人和月经初潮后女性外阴阴道念珠菌病(VVC)的治疗,商品名为Brexafemme■。这是美国FDA近二十多年来批准的首款新型抗真菌类药物,也是唯一可口服或注射治疗的非唑类阴道酵母菌感染的首创新药。该文对治疗深部真菌感染新药——艾瑞芬净的非临床和临床药理毒理学、临床研究、不良反应、适应证、剂量与用法、用药注意事项及知识产权状态和国内外研究进展等进行介绍。

几种常用的核染色标记物pH 6.0 Citrate和pH 9.0 Tris/EDTA修复液的比较

目的探讨pH 6.0 Citrate和pH 9.0 Tris/EDTA两种修复液在常用的免疫组化核染色标记物中的染色效果。方法选取本科室常用的3种核/浆标记抗体以及22种核标记抗体分别采用pH 6.0 Citrate和pH 9.0 Tris/EDTA微波热修复进行比较。结果在25种抗体中,其中有11种分别用pH 6.0 Citrate和pH 9.0 Tris/EDTA微波修复染色效果基本一致,在其余14种抗体中,有11种用pH 9.0 Tris/EDTA微波热修复方法进行修复时,阳性信号明显增强;而有3种抗体用pH 6.0 Citrate微波热修复方法进行修复时,阳性信号稍增强。结论对于这25种抗体来说,如果用微波加热的方法进行抗原修复,那么pH 9.0 Tris/EDTA优于PH 6.0 Citrate。

治疗伴有中至严重血小板减少的骨髓纤维化新药——枸橼酸帕西替尼(pacritinib citrate)

骨髓纤维化是一种罕见的骨髓进行性恶性肿瘤,破坏健康血细胞的正常产生,导致骨髓衰竭和严重贫血。帕西替尼(pacritinib)的激酶谱显示其对急性髓系白血病、骨髓增生异常综合征、慢性单核粒细胞白血病和慢性淋巴细胞白血病具有潜在的治疗作用。枸橼酸帕西替尼最初由美国细胞疗法公司开发,2009年1月与美国S*BIO和Onyx制药公司签订开发和商业化协议,成立美国CTI生物制药公司,重点开发枸橼酸帕西替尼,用于治疗骨髓增生和移植物抗宿主病等疾病。2012年4月,成立CTI生物制药公司,与美国S*BIO和Onyx制药公司重新签订协议,CTI将收回帕西替尼全球开发权利。2020年10月13日CTI生物制药公司向美国食品药品管理局(FDA)提交滚动新药申请,寻求批准枸橼酸帕西替尼用于治疗严重血小板减少症(血小板计数<50×10^(9)·L^(-1))的骨髓纤维化。2022年2月28日,美国FDA批准枸橼酸帕西替尼胶囊上市,商品名Vonjo®,用于治疗成人血小板计数<50×10^(9)·L^(-1)的中高危原发性或继发性(真性红细胞增多症后或原发性血小板增多症)的骨髓纤维化。该文对枸橼酸帕西替尼胶囊的非临床和临床药理毒理学、临床研究、不良反应、适应证、剂量与用法、用药注意事项及知识产权状态和国内外研究进展等进行介绍。

Post-Infectional Biochemical Changes in <i>Cymbopogon martinii</i>(Roxb.) Wats and <i>Cymbopogon citratus</i>(DC) Stapf. Due to Leaf Rust Disease

Post-infectional changes in sugars, ascorbic acid, protein, phenols, chlorophyll and carotene of two Cymbopogons viz., Cymbopogon martinii and Cymbopogon citratus due to leaf rust caused by Puccinia nakanishikii (Diet) were investigated. All the biochemical constituents decreased in plants infected by the fungal pathogen.

Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation

AIM:To evaluate the efficacy and safety of adjunctive mosapride citrate for bowel preparation before colonoscopy. METHODS:We conducted a randomized,double-blind, placebo-controlled study with mosapride in addition to polyethylene glycol(PEG)-electrolyte solution.Of 250 patients undergoing colonoscopy,124 were randomized to receive 2 L PEG plus 15 mg of mosapride citrate (mosapride group),and 126 received 2 L PEG plus placebo(placebo group).Patients completed a questionnaire reporting the acceptability and tolerability of the bowel preparation process.The efficacy of bowel preparation was assessed by colonoscopists using a 5-point scale based on Aronchick's criteria.The primary end point was optimal bowel preparation rates(scores of excellent/good/fair vs poor/inadequate). RESULTS:A total of 249 patients were included in the analysis.In the mosapride group,optimal bowel preparation rates were significantly higher in the left colon compared with the placebo group(78.2%vs 65.6%,P<0.05),but not in the right colon(76.5%vs 66.4%,P=0.08).After excluding patients with severe constipation,there was a significant difference in bowel preparation in both the left and right colon(82.4%vs 66.7%,80.8%vs 67.5%,P<0.05,P<0.01).The incidence of adverse events was similar in both groups. Among the subgroup who had previous colonoscopy experience,a significantly higher number of patients in the mosapride group felt that the current preparation was easier compared with patients in the placebo group(34/72 patients vs 24/74 patients,P<0.05). CONCLUSION:Mosapride citrate may be an effective and safe adjunct to PEG-electrolyte solution that leads to improved quality of bowel preparation,especially in patients without severe constipation.